Price
No data yet.
Social Signal Score
Analyst Ratings
18 analystsRevenue
$387.73M+274.06%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- R. Dirk Allison
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Employees
- 50,659
- Beta
- 0.75
- Country
- US
- Piotroski score
- 6 / 9 (Middling)
- Altman Z-score
- 7.08
Financials
Revenue
$387.73M+274.1%Net Income
$28.59M+277.8%EBITDA
$43.96M+259.0%Free Cash Flow
$38.81MEPS (diluted)
$1.54+133.3%Shares Outstanding (diluted)
18.57M+61.1%Operating Expenses
$80.44MCash & Debt
$98.48MRevenue by Segment (annual)
$1.42BQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $1.42B | $95.91M | $5.19 |
| 2024 | $1.15B | $73.60M | $4.33 |
| 2023 | $1.06B | $62.52M | $3.91 |
| 2022 | $951.12M | $46.02M | $2.90 |
| 2021 | $864.50M | $45.13M | $2.87 |
| 2020 | $764.77M | $33.13M | $2.12 |
| 2019 | $648.79M | $25.24M | $1.83 |
| 2018 | $518.12M | $17.50M | $1.33 |
| 2017 | $425.71M | $13.61M | $1.17 |
| 2016 | $400.69M | $12.02M | $1.04 |
| 2015 | $336.81M | $11.62M | $1.05 |
| 2014 | $312.94M | $12.24M | $1.12 |
| 2013 | $265.94M | $19.14M | $1.77 |
| 2012 | $244.31M | $7.63M | $0.71 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from ADUS's reported EPS growth of 16.5% a year over 13 years.
- EPS in 5 years
- $11.16
- Implied price
- $234.31
- Return from $122.50
- 13.8% a year
To earn 15.0% a year on these assumptions you'd need to buy at $116.49 — -4.9% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 15 | 18 | 21 | 24 | 27 |
|---|---|---|---|---|---|
| 6.5% | -2.7% | 0.9% | 4.1% | 6.9% | 9.4% |
| 11.5% | 1.9% | 5.7% | 9.0% | 11.9% | 14.6% |
| 16.5% | 6.4% | 10.4% | 13.8% | 16.9% | 19.7% |
| 21.5% | 11.0% | 15.1% | 18.7% | 21.9% | 24.9% |
| 26.5% | 15.6% | 19.9% | 23.6% | 27.0% | 30.0% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
175+9.38%Social Signal Score
Mentions (7)
- Newszacks.com·16d ago·Positive
What Makes Addus HomeCare (ADUS) a Strong Momentum Stock: Buy Now? Does Addus HomeCare (ADUS) have what it takes to be a top stock pick for momentum investors? Let's find out.
View source ↗ - Newszacks.com·16d ago·Positive
Addus HomeCare Corporation (ADUS) Hit a 52 Week High, Can the Run Continue? Addus HomeCare (ADUS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
View source ↗ - Newsmarketbeat.com·17d ago·Neutral
Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to Watch Medicare for All is back on Wall Street's radar. Democrats won control of both the House and Senate in the Nov. 3, 2026, midterm elections.
View source ↗ - Newsseekingalpha.com·18d ago·Positive
Addus HomeCare Corporation (ADUS) Q3 2026 Earnings Call Transcript Addus HomeCare Corporation ( ADUS ) Q3 2026 Earnings Call November 4, 2026 9:00 AM EST Company Participants Brandon Cox R. Allison - CEO & Chairman of the Board Brian Poff - CFO, Executive VP, Secretary & Treasurer Conference Call Participants Sean Dodge - BMO Capital Markets Equity Research Benjamin Hendrix - RBC Capital Markets, Research Division Andrew Mok - Barclays Bank PLC, Research Division Brian Tanquilut - Jefferies LLC,…
View source ↗ - Newsmarketbeat.com·18d ago·Neutral
Addus HomeCare Q3 Earnings Call Highlights Addus HomeCare NASDAQ: ADUS reported third-quarter 2026 revenue of $387.7 million, up 7% from $362.3 million in the prior-year period, while adjusted earnings per diluted share rose 17.3% to $1.83. Adjusted EBITDA increased 13.5% to $51.2 million, and the company said its cost discipline and operating leverage helped earnings growth outpace revenue growth.
View source ↗ - Newszacks.com·19d ago·Neutral
Addus HomeCare (ADUS) Reports Q3 Earnings: What Key Metrics Have to Say Although the revenue and EPS for Addus HomeCare (ADUS) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
View source ↗ - Newszacks.com·19d ago·Positive
Addus HomeCare (ADUS) Surpasses Q3 Earnings Estimates Addus HomeCare (ADUS) came out with quarterly earnings of $1.83 per share, beating the Zacks Consensus Estimate of $1.78 per share. This compares to earnings of $1.56 per share a year ago.
View source ↗
Earnings
Mon, Feb 22(in 3 months)
Consensus estimate $1.88 per share
Typical surprise +2.8% (median, so one quarter with a near-zero estimate can't distort it)
- Tue, Nov 3$1.83 vs $1.79beat
- Mon, Aug 3$1.73 vs $1.70beat
- Mon, May 4$1.62 vs $1.52beat
- Mon, Feb 23$1.77 vs $1.71beat
- Mon, Nov 3$1.56 vs $1.53beat
- Mon, Aug 4$1.49 vs $1.45beat
Estimates and results for ADUS via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by ADUS officers and directors.
- Bought
- —
- Sold
- $27.4m
0 trades
64 trades
- Anderson Darbysold
- Anderson Darbysold
- Blessing Cliff Donaldsold
- Blessing Cliff Donaldsold
- Blessing Cliff Donaldsold
- Allison R Dirksold
- Allison R Dirksold
- Allison R Dirksold
36 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
- Donna Shalalahouse · FL27 · disclosed Apr 27, 2020 (308d later)Sell$1,001 - $15,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
